Delivery Order SPE2DB22D2007-SPE2DB25FH8EV

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,432.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of AZASITE 1% eye drops, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of November 14, 2024 and is a firm fixed-price arrangement. It is not designated as a set-aside contract....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,258.19 firm-fixed-price delivery order is for the supply of AZASITE 1% eye drops in 2.5 ml containers. The award has an ultimate completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as a prime contractor without any set-aside designation. The contract is part of the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of the pharmaceutical product AZASITE 1% eye drops in 2.5 milliliter vials. The contract is valued at $1,474.02 and has a period of performance through September 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical,...
Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $628.20 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 4561858342 AZASITE 1% EYE DROPS 2.5ML. Performance will take place in Conshohocken, Pennsylvania over a period of three days from August 18th through the 21st of 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $54,566.54 firm-fixed-price delivery order is for the supply of AZOPT 1% eye drops with an ultimate completion date of July 15, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This delivery order for $314 worth of AZASITE 1% EYE DROPS 2.5ML was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp on October 19, 2023. The contract has a firm fixed price and is to be completed by October 20, 2023. To be performed in Conshohocken, Pennsylvania, this order is likely associated with the Defense Logistics Agency's medical supply chain and will provide the specified eye drops to DLA or its customers by the completion date. No set-aside provision was applied...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $4,577.85 issued by the Defense Logistics Agency (DLA). It covers the procurement of 0.1% eye drop medication, 2ml size, with a completion date of January 6, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary contracting vehicle for...
The Defense Logistics Agency awarded a $157 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562031421 AZASITE 1% eye drops. The order is for 2.5mL bottles of the eye drops and will be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility between September 1-5, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor that supports the Defense Logistics Agency's medical supply needs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676 firm fixed-price delivery order is for the supply of 4566712202 - AZOPT 1% Eye Drops, 10ML. The contract has an ultimate completion date of December 16, 2024 and does not utilize any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency awarded a $409,600 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for 4562138161 AZASITE 1% eye drops. As the prime contractor, Amerisourcebergen will supply the requested pharmaceutical products to the Defense Logistics Agency by September 13, 2023 from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the global supply chain for the United...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8EV
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,085.86 firm-fixed-price delivery order is for AZASITE 1% EYE DROPS 2.5ML, a pharmaceutical product.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. The DLA, as a defense agency, procures medical products and services to support the healthcare needs of military personnel and veterans.

Generated 4/14/25, 10:26 AM